Profiling of Canonical and Non-Traditional Cytokine Levels in Interferon-β-Treated Relapsing-Remitting-Multiple Sclerosis Patients.

Front Immunol · 2018 · PMC5994428 · PMID 29915590

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

In our cohort of IFN-β-treated patients, serum levels of IL-37 appeared as an increasing trend compared to untreated patients [3.38 (IQR: 2.51–4.68) vs 3.04 (IQR: 2.59–6.01)] and the same relationship was found for TGF-β1 [27,871.75 (IQR: 22,672.83−32,873.73) vs 21985.20 (IQR: 19,425.04–33,815.69)].

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.